Deborah Richardson

Southampton Hospital — United States

Medicine · Health Sciences

15h-index840citations53works1.52yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Acute Myeloid Leukemia Research(11), Hematopoietic Stem Cell Transplantation(11), Acute Lymphoblastic Leukemia research(7), Chronic Myeloid Leukemia Treatments(7), Lymphoma Diagnosis and Treatment(6)

Publications52 total

Allogeneic Hematopoietic Stem Cell Transplantation in ERCC6L2 Disease
Blood Advances·2026Open Access
Fertility after CAR T-Cell Therapy, a Survey on Management and Outcomes from the Cellular Therapy and Immunobiology Working Party of the EBMT
SSRN Electronic Journal·2026Open Access
CAR T-cell therapy versus autologous HSCT in patients with large B-cell lymphoma in complete remission: An analysis from the EBMT lymphoma working party
Blood·2025Open Access
An updated UK real-world analysis of factors affecting outcome following brexucabtagene autoleucel for relapsed or refractory adult acute lymphoblastic leukemia
Blood·2025Open Access
INO-transit: Inotuzumab ozogamicin treatment prior to chimeric antigen receptor T-cell therapy in Relapsed/Refractory B-cell acute lymphoblastic leukemia: Real-world patient characteristics and outcomes in Spain, the UK and US
Blood·2025
Outcomes of multiple myeloma (MM) patients with del 17p as a sole high risk cytogenetic abnormality who underwent either single or tandem upfront autologous stem cell transplant approaches in EBMT centres between 2016 and 2022
Blood·2025
A survey on the practices and the management of hemorrhagic cystitis in patients who undergo allogeneic hematopoietic stem cell transplantation, on behalf of the Infectious Diseases Working Party of EBMT
Bone Marrow Transplantation·2025Open Access
86 | EFFICACY OF THIOTEPA‐CONDITIONED AUTOLOGOUS TRANSPLANTATION IS INDEPENDENT OF RESPONSE TO HD‐MTX‐BASED INDUCTION IN PRIMARY CNS LYMPHOMA: EBMT SERIES OF 1545 PATIENTS
Hematological Oncology·2025Open Access
Current use of donor lymphocyte infusions after allogenic stem cell transplantation in Europe: a survey on behalf of the cellular therapy and immunobiology working party of the EBMT
Bone Marrow Transplantation·2025· 4 citedOpen Access
A UK Intention to Treat Analysis of Brexucabtagene Autoleucel for Relapsed or Refractory Adult Acute Lymphoblastic Leukaemia Following 1 Year of Therapy Access
Blood·2024Open Access
Evaluation and management of hepatic dysfunction, portal hypertension and portal/splanchnic vein thrombosis in patients with myelofibrosis undergoing allogeneic haematopoietic cell transplantation: A practice based survey on behalf of the Chronic Malignancies Working Party of the EBMT
Current Research in Translational Medicine·2024· 2 citedOpen Access
Efficient bone marrow irradiation and low uptake by non-haematological organs with an yttrium-90-anti-CD66 antibody prior to haematopoietic stem cell transplantation
Bone Marrow Transplantation·2024· 5 citedOpen Access
Allogeneic hematopoietic stem-cell transplantation for patients with Richter transformation: a retrospective study on behalf of the Chronic Malignancies Working Party of the EBMT
Bone Marrow Transplantation·2024· 8 citedOpen Access
Salvage Transplant Versus CAR-T Cell Therapy for Relapsed Multiple Myeloma
Blood·2023· 4 citedOpen Access
In Vivo Generation of Memory-like NK Cells for the Treatment of AML and Myelodysplastic Syndrome; Early Clinical Applications of INKmuneTM
Blood·2022· 1 cited
Long‐term outcome of patients receiving haematopoietic allogeneic stem cell transplantation as first transplant for high‐risk Hodgkin lymphoma: a retrospective analysis from the Lymphoma Working Party‐EBMT
British Journal of Haematology·2021· 3 cited
Adjuvant tyrosine kinase inhibitor therapy improves outcome for children and adolescents with acute lymphoblastic leukaemia who have an ABL‐class fusion
British Journal of Haematology·2020· 47 citedOpen Access
Mesenchymal stromal cells for acute graft‐versus‐host disease: response at 1 week predicts probability of survival
British Journal of Haematology·2019· 40 citedOpen Access
UK consensus statement on the use of plerixafor to facilitate autologous peripheral blood stem cell collection to support high‐dose chemoradiotherapy for patients with malignancy
Journal of Clinical Apheresis·2017· 47 cited
Fludarabine, Melphalan and Alemtuzumab Conditioned Reduced Intensity (RIC) Allogeneic Hematopoietic Cell Transplantation for Adults Aged >40 Years with De Novo Acute Lymphoblastic Leukemia: A Prospective Study from the UKALL14 Trial (ISRCTN 66541317)
Blood·2015· 10 cited
page 1 of 3Next →

Frequent Co-authors

Kim Orchard(14), Adrian C. Newland(7), Joan Newman(6), Carol Hurlock(5), Nikki McKeag(5), Kavita Raj(5), David I. Marks(5), Stephen A. Johnson(5), Kate Hill(4), Anna Castleton(4), Eleni Tholouli(4), Joanna Drozd‐Sokołowska(4), Donal P. McLornan(4), Emma Nicholson(4), Amy Publicover(3), Anthony V. Moorman(3), Patrick Hayden(3), Hannah Hunter(3), Ram Malladi(3), Keith Wilson(3)